What is the recommended dose of Gynazole (Butoconazole) for treating vaginal yeast infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gynazole (Butoconazole) Dosing for Vaginal Yeast Infections

The recommended dose of Gynazole (butoconazole nitrate 2% vaginal cream) is one applicatorful (approximately 5 grams containing 100 mg of butoconazole nitrate) administered intravaginally as a single dose. 1

Administration Details

  • Apply one full applicator of butoconazole nitrate 2% cream intravaginally as a single application to the posterior vaginal fornix 1
  • This single-dose formulation uses a bioadhesive, sustained-release delivery system that maintains therapeutic levels over several days 2, 3

Clinical Efficacy of Single-Dose Therapy

  • Single-dose butoconazole provides rapid symptom relief, with median time to first symptom relief at 17.5 hours compared to 22.9 hours for oral fluconazole 2
  • By 24 hours post-treatment, 72.8% of patients report first relief of symptoms 2
  • Clinical cure rates at 8-10 days post-treatment reach 92%, with negative fungal cultures in 87% of patients 3
  • At 30-day follow-up, 88% of patients remain clinically cured with 74% maintaining negative cultures 3

Advantages Over Multi-Day Regimens

  • The single-dose formulation improves patient compliance compared to 3-day or 7-day treatment courses 4
  • Severe symptoms decline from 20% at baseline to 6% by day 1 and 3% by day 4 after single application 3
  • Symptom relief occurs significantly faster with single-dose butoconazole compared to the first dose of multi-day miconazole therapy (P = 0.01) 3

Safety Profile

  • Local adverse events are minimal, with vulvovaginal pruritus and burning being the most common drug-related effects 2
  • Butoconazole demonstrates fewer overall adverse events compared to oral fluconazole 2
  • Only 2 out of 223 patients discontinued treatment due to increased vulvovaginal irritation in clinical trials 4

Important Clinical Caveats

  • If symptoms persist beyond 7 days, reassess the diagnosis as alternative etiologies should be considered 5
  • Follow-up is only needed if symptoms persist after treatment completion or recur within 2 months 5
  • As with other azole vaginal preparations, butoconazole cream may weaken latex condoms and diaphragms 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.